Similar articles for PMID: 22058329

Year	Number of Results
1997	1
1998	1
1999	1
2000	3
2001	1
2003	10
2004	3
2005	3
2006	4
2007	7
2008	11
2009	11
2010	16
2011	19
2012	13
2013	17
2014	15
2015	17
2016	18
2017	10
2018	15
2019	14
2020	15
2021	11
2022	10
2023	3
2024	1

1

Endogenous osteopontin involvement in laser-induced choroidal neovascularization in mice.

Fujita N, Fujita S, Ogata N, Matsuoka M, Okada Y, Kon S, Uede T, Saika S. Fujita N, et al. Invest Ophthalmol Vis Sci. 2011 Dec 2;52(13):9310-5. doi: 10.1167/iovs.10-7050. Invest Ophthalmol Vis Sci. 2011. PMID: 22058329

2

Laser-induced choroidal neovascularization in mice attenuated by deficiency in the apelin-APJ system.

Hara C, Kasai A, Gomi F, Satooka T, Sakimoto S, Nakai K, Yoshioka Y, Yamamuro A, Maeda S, Nishida K. Hara C, et al. Invest Ophthalmol Vis Sci. 2013 Jun 21;54(6):4321-9. doi: 10.1167/iovs.13-11611. Invest Ophthalmol Vis Sci. 2013. PMID: 23722395

3

Effects of an anti-VEGF-A monoclonal antibody on laser-induced choroidal neovascularization in mice: optimizing methods to quantify vascular changes.

Campa C, Kasman I, Ye W, Lee WP, Fuh G, Ferrara N. Campa C, et al. Invest Ophthalmol Vis Sci. 2008 Mar;49(3):1178-83. doi: 10.1167/iovs.07-1194. Invest Ophthalmol Vis Sci. 2008. PMID: 18326747

4

Blockage of tissue factor ameliorates the lesion of laser-induced choroidal neovascularization in mice.

Wang L, Yang Z, Yu Y, Cui C, Guan H, Chen H. Wang L, et al. Exp Eye Res. 2014 Oct;127:117-23. doi: 10.1016/j.exer.2014.07.006. Epub 2014 Jul 22. Exp Eye Res. 2014. PMID: 25063201

5

Inhibition of experimental choroidal neovascularization in mice by anti-VEGFA/VEGFR2 or non-specific siRNA.

Gu L, Chen H, Tuo J, Gao X, Chen L. Gu L, et al. Exp Eye Res. 2010 Sep;91(3):433-9. doi: 10.1016/j.exer.2010.06.019. Epub 2010 Jul 1. Exp Eye Res. 2010. PMID: 20599960

6

Angiography of fluoresceinated anti-vascular endothelial growth factor antibody and dextrans in experimental choroidal neovascularization.

Tolentino MJ, Husain D, Theodosiadis P, Gragoudas ES, Connolly E, Kahn J, Cleland J, Adamis AP, Cuthbertson A, Miller JW. Tolentino MJ, et al. Arch Ophthalmol. 2000 Jan;118(1):78-84. doi: 10.1001/archopht.118.1.78. Arch Ophthalmol. 2000. PMID: 10636419

7

Suppression of laser-induced choroidal neovascularization by nontargeted siRNA.

Ashikari M, Tokoro M, Itaya M, Nozaki M, Ogura Y. Ashikari M, et al. Invest Ophthalmol Vis Sci. 2010 Jul;51(7):3820-4. doi: 10.1167/iovs.09-5121. Epub 2010 Feb 3. Invest Ophthalmol Vis Sci. 2010. PMID: 20130283

8

Suppression of choroidal neovascularization by vasohibin-1, a vascular endothelium-derived angiogenic inhibitor.

Wakusawa R, Abe T, Sato H, Sonoda H, Sato M, Mitsuda Y, Takakura T, Fukushima T, Onami H, Nagai N, Ishikawa Y, Nishida K, Sato Y. Wakusawa R, et al. Invest Ophthalmol Vis Sci. 2011 May 17;52(6):3272-80. doi: 10.1167/iovs.10-6295. Invest Ophthalmol Vis Sci. 2011. PMID: 21345982

9

Reliability of the mouse model of choroidal neovascularization induced by laser photocoagulation.

Poor SH, Qiu Y, Fassbender ES, Shen S, Woolfenden A, Delpero A, Kim Y, Buchanan N, Gebuhr TC, Hanks SM, Meredith EL, Jaffee BD, Dryja TP. Poor SH, et al. Invest Ophthalmol Vis Sci. 2014 Sep 9;55(10):6525-34. doi: 10.1167/iovs.14-15067. Invest Ophthalmol Vis Sci. 2014. PMID: 25205860

10

Suppression of choroidal neovascularization in lectin-like oxidized low-density lipoprotein receptor type 1-deficient mice.

Inomata Y, Fukushima M, Hara R, Takahashi E, Honjo M, Koga T, Kawaji T, Satoh H, Takeya M, Sawamura T, Tanihara H. Inomata Y, et al. Invest Ophthalmol Vis Sci. 2009 Aug;50(8):3970-6. doi: 10.1167/iovs.07-1177. Epub 2009 Jan 31. Invest Ophthalmol Vis Sci. 2009. PMID: 19182261

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

223 results

Results by year